OTC Artificial Tears Market by Product Type (Solution, Ointment, Emulsion, Gel, Spray Solution, and Suspensions), Container Type (Plastic Single Dose Container, Plastic Multi-Dose Container, and Spray), Formulation (Preservative Based and Non-Preservative Based), Application (Dry Eye Syndrome, Allergies, Infections, UV and Blue Light Protection, Contact Lens Moisture Retention, and Others), and Distribution Channel (Hospital Pharmacies, Drug Stores, and Retail Pharmacies & Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021––2028
- ALL4621679
- 376 Pages
- May 2021
- Medical Devices
Artificial tears also known as ocular lubricants are eye drops that are used to lubricate dry eyes and maintain moisture on the outer surface of the eye for a longer duration of time. Over-the-counter (OTC) artificial tears are the products that are available directly to the consumer without prescription.
The global OTC artificial tears market is majorly driven by rise in geriatric population; an alarming increase in the prevalence of dry eye syndrome (DES); and a rise in the number of eye surgeries which increases the demand for artificial tear drops for post-surgery management. For instance, according to the World Health Organization (WHO), in 2021, approximately 2.2 billion population in the world was reported to be diagnosed with vision impairment. As per the data published in BioMed Central (BMC) Ophthalmology, in 2020, a total of 90% population across the globe suffered from dry eye syndrome. Moreover, the geriatric population is more vulnerable to dry eye syndrome due to inadequate tear production from lacrimal gland, altered reflex secretion or inflammatory destruction of the lacrimal glands. For instance, as per the data published by the Journal of the United Nations, 962 million population were present above the age of 60 years in 2017 which is expected to get double to nearly 2.1 billion by the year of 2050. Thus, the rise in the geriatric population and increase in prevalence of dry eye syndrome are expected to propel the demand for OTC artificial tears, which, in turn, augments the market growth. Furthermore, the increase in number of eye surgeries, upsurge the need of artificial tear drops for the post-surgical management.
Furthermore, OTC artificial tears play an important role in the global healthcare sector. Availability of different dosage forms of OTC artificial tears such as drops, ointment, emulsion, spray solution, and gel is used for providing relief from irritation, burning, and discomfort which is caused due to dry eye syndrome. Moreover, rise in investment and activities in R&D by various healthcare sectors for the development of new OTC artificial tears, such as REFRESH DIGITAL lubricant eye drop (AbbVie Inc.), drive the growth of the global market. Upsurge in technological advancement and rise in the number of people wearing contact lens, also increases the demand for OTC artificial tear and propel the growth of the market. In addition, change in the lifestyle habit such as prolong exposure to digital display and the surge in number of smartphone addicts, causes dry eye syndrome that increase the usage of artificial tears and boosts the market growth.
On the contrary, the risk of contamination associated with OTC artificial tears and adverse reaction due to presence of preservative in the formulations is anticipated to hinder the market growth during the forecast period. The adverse reactions caused due to use of artificial tear products include blurred vision, eye pain, skin rash, and redness around the eye.
The OTC artificial tears market is segmented into product type, container type, formulation, application, distribution channel and region. Depending on product type, the market is segmented into solution, ointment, emulsion, gel, spray solution and suspension. On the basis of container type, the market is fragmented into the plastic single dose container, plastic multi-dose container and spray. The plastic single dose container segment is further classified into preservative free system and preserved system. Further, the spray segment is further bifurcated into preservative free system and preserved system. On the basic of formulation, it is differentiated into preservative based and non-preservative based. By application, the global market is segregated into dry eye syndrome, allergies, infections, UV & blue light protection, contact lens moisture retention and others.
As per distribution channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. At regional level, the OTC artificial tears market is analyzed across North America, Europe, Asia-Pacific, Middle East, North-Africa and Rest of World.
The report provides an extensive competitive analysis and profiles of the key market players such as AbbVie, Inc., Akorn, Inc., Alcon, Bausch & Lomb, Johnson & Johnson, Ocusoft, Santen Pharmaceutical Co. Ltd, Similasan Corporation, Sun Pharmaceutical Industries Limited and Ursapharm Arzneimittel GmbH.
KEY BENEFITS FOR STAKEHOLDERS
The report provides an in-depth analysis of the global OTC artificial tears market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers market analysis from 2021 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global OTC artificial tears market.
KEY MARKET SEGMENTS
By Product
• Solution
• Ointment
• Emulsion
• Gel
• Spray Solution
• Suspensions
By Container Type
• Plastic Single Dose Container
• Plastic multi-dose containers
o Preservative-Free System
o Preserved System
• Spray
o Preservative-Free System
o Preserved System
By Formulation
• Preservative Based
• Non-Preservative Based
By Application
• Dry Eye Syndrome
• Allergies
• Infections
• UV & Blue Light Protection
• Contact Lens Moisture Retention
• Others
By Distribution Channel
• Hospital Pharmacies
• Drug Store & Retail Pharmacies
• Online Pharmacies
By Region
o North America
U.S.
Rest of North America
o Europe
UK
Germany
France
Italy
Spain
Poland
Rest of Europe
o Asia-Pacific
Japan
China
India
Malaysia
Thailand
Philippines
Rest of Asia-Pacific
o Middle East
UAE
Saudi Arabia
Palestine
Jordan
Bahrain
Qatar
Azerbaijan
Georgia
Iraq
Pakistan
Kuwait
Israel
Kazakhstan
Rest of Middle East
o North Africa
Morocco
Algeria
Tunisia
Libya
Egypt
Rest of North Africa
o Rest of World
KEY MARKET PLAYERS
• AbbVie, Inc.
• Akorn, Inc.
• Alcon
• Bausch and Lamb
• Johnson and Johnson
• OcuSoft
• Santen Pharmaceutical Co. Ltd
• Similasan Corporation
• Sun Pharmaceutical Industries Limited
• Ursapharm Arzneimittel GmbH
1.1.REPORT DESCRIPTION
1.2.KEY MARKET SEGMENTS
1.3.KEY BENEFITS
1.4.RESEARCH METHODOLOGY
1.4.1.Primary research
1.4.2.Secondary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO PERSPECTIVE
CHAPTER 3:MARKET LANDSCAPE
3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.PORTER'S FIVE FORCES ANALYSIS
3.3.1.Bargaining power of suppliers
3.3.2.Threat of new entrants
3.3.3.Threat of substitutes
3.3.4.Competitive rivalry
3.3.5.Bargaining power among buyers
3.4.MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING 2019
3.5.MARKET DYNAMICS
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.IMPACT ANALYSIS OF COVID-19 ON MARKET
CHAPTER 4:OTC ARTIFICIAL TEARS MARKET BY PRODUCT TYPE
4.1.OVERVIEW
4.2.SOLUTION
4.2.1.Key market trends, growth factors and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market share analysis, by country
4.3.OINTMENT
4.3.1.Key market trends, growth factors and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market share analysis, by country
4.4.EMULSION
4.4.1.Key market trends, growth factors and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market share analysis, by country
4.5.GEL
4.5.1.Key market trends, growth factors and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market share analysis, by country
4.6.SPRAY SOLUTION
4.6.1.Key market trends, growth factors and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market share analysis, by country
4.7.SUSPENSIONS
4.7.1.Key market trends, growth factors and opportunities
4.7.2.Market size and forecast, by region
4.7.3.Market share analysis, by country
CHAPTER 5:OTC ARTIFICIAL TEARS MARKET BY CONTAINER TYPE
5.1.OVERVIEW
5.2.PLASTIC SINGLE DOSE CONTAINER
5.2.1.Key market trends, growth factors and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market share analysis, by country
5.3.PLASTIC MULTI-DOSE CONTAINER
5.3.1.Key market trends, growth factors and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market share analysis, by country
5.3.4.Preservative-free system
5.3.4.1.Market size and forecast
5.3.5.Preserved Systems
5.3.5.1.Market size and forecast
5.4.SPRAY
5.4.1.Key market trends, growth factors and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market share analysis, by country
5.4.4.Preservative-free system
5.4.4.1.Market size and forecast
5.4.5.Preserved Systems
5.4.5.1.Market size and forecast
CHAPTER 6:OTC ARTIFICIAL TEARS MARKET BY FORMULATION
6.1.OVERVIEW
6.2.PRESERVATIVE BASED
6.2.1.Key market trends, growth factors and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market share analysis, by country
6.3.NON-PRESERVATIVE BASED
6.3.1.Key market trends, growth factors and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market share analysis, by country
CHAPTER 7:OTC ARTIFICIAL TEARS MARKET BY APPLICATION
7.1.OVERVIEW
7.2.DRY EYE SYNDROME
7.2.1.Key market trends, growth factors and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market share analysis, by country
7.3.ALLERGIES
7.3.1.Key market trends, growth factors and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market share analysis, by country
7.4.INFECTIONS
7.4.1.Key market trends, growth factors and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market share analysis, by country
7.5.UV AND BLUE LIGHT PROTECTION
7.5.1.Key market trends, growth factors and opportunities
7.5.2.Market size and forecast, by region
7.5.3.Market share analysis, by country
7.6.CONTACT LENS MOISTURE RETENTION
7.6.1.Key market trends, growth factors and opportunities
7.6.2.Market size and forecast, by region
7.6.3.Market share analysis, by country
7.7.OTHERS
7.7.1.Key market trends, growth factors and opportunities
7.7.2.Market size and forecast, by region
7.7.3.Market share analysis, by country
CHAPTER 8:OTC ARTIFICIAL TEARS MARKET BY DISTRIBUTION CHANNEL
8.1.OVERVIEW
8.2.HOSPITAL PHARMACIES
8.2.1.Key market trends, growth factors and opportunities
8.2.2.Market size and forecast, by region
8.2.3.Market share analysis, by country
8.3.DRUG STORE AND RETAIL PHARMACIES
8.3.1.Key market trends, growth factors and opportunities
8.3.2.Market size and forecast, by region
8.3.3.Market share analysis, by country
8.4.ONLINE PHARMACIES
8.4.1.Key market trends, growth factors and opportunities
8.4.2.Market size and forecast, by region
8.4.3.Market share analysis, by country
CHAPTER 9:OTC ARTIFICIAL TEARS MARKET BY REGION
9.1.OVERVIEW
9.2.NORTH AMERICA
9.2.1.Key market trends and opportunities
9.2.2.Market size and forecast, by product type
9.2.3.Market size and forecast, by container type
9.2.4.Market size and forecast, by formulation
9.2.5.Market size and forecast, by application
9.2.6.Market size and forecast, by distribution channel
9.2.7.Market size and forecast, by Country
9.2.8.U.S.
9.2.8.1.Market size and forecast, by product type
9.2.8.2.Market size and forecast, by container type
9.2.8.3.Market size and forecast, by formulation
9.2.8.4.Market size and forecast, by application
9.2.8.5.Market size and forecast, by distribution channel
9.2.9.Rest of North America
9.2.9.1.Market size and forecast, by product type
9.2.9.2.Market size and forecast, by container type
9.2.9.3.Market size and forecast, by formulation
9.2.9.4.Market size and forecast, by application
9.2.9.5.Market size and forecast, by distribution channel
9.3.EUROPE
9.3.1.Key market trends and opportunities
9.3.2.Market size and forecast, by product type
9.3.3.Market size and forecast, by container type
9.3.4.Market size and forecast, by formulation
9.3.5.Market size and forecast, by application
9.3.6.Market size and forecast, by distribution channel
9.3.7.Market size and forecast, by Country
9.3.8.UK
9.3.8.1.Market size and forecast, by product type
9.3.8.2.Market size and forecast, by container type
9.3.8.3.Market size and forecast, by formulation
9.3.8.4.Market size and forecast, by application
9.3.8.5.Market size and forecast, by distribution channel
9.3.9.Germany
9.3.9.1.Market size and forecast, by product type
9.3.9.2.Market size and forecast, by container type
9.3.9.3.Market size and forecast, by formulation
9.3.9.4.Market size and forecast, by application
9.3.9.5.Market size and forecast, by distribution channel
9.3.10.France
9.3.10.1.Market size and forecast, by product type
9.3.10.2.Market size and forecast, by container type
9.3.10.3.Market size and forecast, by formulation
9.3.10.4.Market size and forecast, by application
9.3.10.5.Market size and forecast, by distribution channel
9.3.11.Italy
9.3.11.1.Market size and forecast, by product type
9.3.11.2.Market size and forecast, by container type
9.3.11.3.Market size and forecast, by formulation
9.3.11.4.Market size and forecast, by application
9.3.11.5.Market size and forecast, by distribution channel
9.3.12.Spain
9.3.12.1.Market size and forecast, by product type
9.3.12.2.Market size and forecast, by container type
9.3.12.3.Market size and forecast, by formulation
9.3.12.4.Market size and forecast, by application
9.3.12.5.Market size and forecast, by distribution channel
9.3.13.Poland
9.3.13.1.Market size and forecast, by product type
9.3.13.2.Market size and forecast, by container type
9.3.13.3.Market size and forecast, by formulation
9.3.13.4.Market size and forecast, by application
9.3.13.5.Market size and forecast, by distribution channel
9.3.14.Rest of Europe
9.3.14.1.Market size and forecast, by product type
9.3.14.2.Market size and forecast, by container type
9.3.14.3.Market size and forecast, by formulation
9.3.14.4.Market size and forecast, by application
9.3.14.5.Market size and forecast, by distribution channel
9.4.ASIA-PACIFIC
9.4.1.Key market trends and opportunities
9.4.2.Market size and forecast, by product type
9.4.3.Market size and forecast, by container type
9.4.4.Market size and forecast, by formulation
9.4.5.Market size and forecast, by application
9.4.6.Market size and forecast, by distribution channel
9.4.7.Market size and forecast, by Country
9.4.8.Japan
9.4.8.1.Market size and forecast, by product type
9.4.8.2.Market size and forecast, by container type
9.4.8.3.Market size and forecast, by formulation
9.4.8.4.Market size and forecast, by application
9.4.8.5.Market size and forecast, by distribution channel
9.4.9.China
9.4.9.1.Market size and forecast, by product type
9.4.9.2.Market size and forecast, by container type
9.4.9.3.Market size and forecast, by formulation
9.4.9.4.Market size and forecast, by application
9.4.9.5.Market size and forecast, by distribution channel
9.4.10.India
9.4.10.1.Market size and forecast, by product type
9.4.10.2.Market size and forecast, by container type
9.4.10.3.Market size and forecast, by formulation
9.4.10.4.Market size and forecast, by application
9.4.10.5.Market size and forecast, by distribution channel
9.4.11.Malaysia
9.4.11.1.Market size and forecast, by product type
9.4.11.2.Market size and forecast, by container type
9.4.11.3.Market size and forecast, by formulation
9.4.11.4.Market size and forecast, by application
9.4.11.5.Market size and forecast, by distribution channel
9.4.12.Vietnam
9.4.12.1.Market size and forecast, by product type
9.4.12.2.Market size and forecast, by container type
9.4.12.3.Market size and forecast, by formulation
9.4.12.4.Market size and forecast, by application
9.4.12.5.Market size and forecast, by distribution channel
9.4.13.Thailand
9.4.13.1.Market size and forecast, by product type
9.4.13.2.Market size and forecast, by container type
9.4.13.3.Market size and forecast, by formulation
9.4.13.4.Market size and forecast, by application
9.4.13.5.Market size and forecast, by distribution channel
9.4.14.Philippines
9.4.14.1.Market size and forecast, by product type
9.4.14.2.Market size and forecast, by container type
9.4.14.3.Market size and forecast, by formulation
9.4.14.4.Market size and forecast, by application
9.4.14.5.Market size and forecast, by distribution channel
9.4.15.Rest of Asia-Pacific
9.4.15.1.Market size and forecast, by product type
9.4.15.2.Market size and forecast, by container type
9.4.15.3.Market size and forecast, by formulation
9.4.15.4.Market size and forecast, by application
9.4.15.5.Market size and forecast, by distribution channel
9.5.MIDDLE EAST
9.5.1.Key market trends and opportunities
9.5.2.Market size and forecast, by product type
9.5.3.Market size and forecast, by container type
9.5.4.Market size and forecast, by formulation
9.5.5.Market size and forecast, by application
9.5.6.Market size and forecast, by distribution channel
9.5.7.Market size and forecast, by Country
9.5.8.UAE
9.5.8.1.Market size and forecast, by product type
9.5.8.2.Market size and forecast, by container type
9.5.8.3.Market size and forecast, by formulation
9.5.8.4.Market size and forecast, by application
9.5.8.5.Market size and forecast, by distribution channel
9.5.9.Saudi Arabia
9.5.9.1.Market size and forecast, by product type
9.5.9.2.Market size and forecast, by container type
9.5.9.3.Market size and forecast, by formulation
9.5.9.4.Market size and forecast, by application
9.5.9.5.Market size and forecast, by distribution channel
9.5.10.Palestine
9.5.10.1.Market size and forecast, by product type
9.5.10.2.Market size and forecast, by container type
9.5.10.3.Market size and forecast, by formulation
9.5.10.4.Market size and forecast, by application
9.5.10.5.Market size and forecast, by distribution channel
9.5.11.Jordan
9.5.11.1.Market size and forecast, by product type
9.5.11.2.Market size and forecast, by container type
9.5.11.3.Market size and forecast, by formulation
9.5.11.4.Market size and forecast, by application
9.5.11.5.Market size and forecast, by distribution channel
9.5.12.Bahrein
9.5.12.1.Market size and forecast, by product type
9.5.12.2.Market size and forecast, by container type
9.5.12.3.Market size and forecast, by formulation
9.5.12.4.Market size and forecast, by application
9.5.12.5.Market size and forecast, by distribution channel
9.5.13.Qatar
9.5.13.1.Market size and forecast, by product type
9.5.13.2.Market size and forecast, by container type
9.5.13.3.Market size and forecast, by formulation
9.5.13.4.Market size and forecast, by application
9.5.13.5.Market size and forecast, by distribution channel
9.5.14.Azerbaijan
9.5.14.1.Market size and forecast, by product type
9.5.14.2.Market size and forecast, by container type
9.5.14.3.Market size and forecast, by formulation
9.5.14.4.Market size and forecast, by application
9.5.14.5.Market size and forecast, by distribution channel
9.5.15.Georgia
9.5.15.1.Market size and forecast, by product type
9.5.15.2.Market size and forecast, by container type
9.5.15.3.Market size and forecast, by formulation
9.5.15.4.Market size and forecast, by application
9.5.15.5.Market size and forecast, by distribution channel
9.5.16.Iraq
9.5.16.1.Market size and forecast, by product type
9.5.16.2.Market size and forecast, by container type
9.5.16.3.Market size and forecast, by formulation
9.5.16.4.Market size and forecast, by application
9.5.16.5.Market size and forecast, by distribution channel
9.5.17.Pakistan
9.5.17.1.Market size and forecast, by product type
9.5.17.2.Market size and forecast, by container type
9.5.17.3.Market size and forecast, by formulation
9.5.17.4.Market size and forecast, by application
9.5.17.5.Market size and forecast, by distribution channel
9.5.18.Kuwait
9.5.18.1.Market size and forecast, by product type
9.5.18.2.Market size and forecast, by container type
9.5.18.3.Market size and forecast, by formulation
9.5.18.4.Market size and forecast, by application
9.5.18.5.Market size and forecast, by distribution channel
9.5.19.Israel
9.5.19.1.Market size and forecast, by product type
9.5.19.2.Market size and forecast, by container type
9.5.19.3.Market size and forecast, by formulation
9.5.19.4.Market size and forecast, by application
9.5.19.5.Market size and forecast, by distribution channel
9.5.20.Kazakhstan
9.5.20.1.Market size and forecast, by product type
9.5.20.2.Market size and forecast, by container type
9.5.20.3.Market size and forecast, by formulation
9.5.20.4.Market size and forecast, by application
9.5.20.5.Market size and forecast, by distribution channel
9.5.21.Rest of Middle East
9.5.21.1.Market size and forecast, by product type
9.5.21.2.Market size and forecast, by container type
9.5.21.3.Market size and forecast, by formulation
9.5.21.4.Market size and forecast, by application
9.5.21.5.Market size and forecast, by distribution channel
9.6.NORTH AFRICA
9.6.1.Key market trends and opportunities
9.6.2.Market size and forecast, by product type
9.6.3.Market size and forecast, by container type
9.6.4.Market size and forecast, by formulation
9.6.5.Market size and forecast, by application
9.6.6.Market size and forecast, by distribution channel
9.6.7.Market size and forecast, by Country
9.6.8.Morocco
9.6.8.1.Market size and forecast, by product type
9.6.8.2.Market size and forecast, by container type
9.6.8.3.Market size and forecast, by formulation
9.6.8.4.Market size and forecast, by application
9.6.8.5.Market size and forecast, by distribution channel
9.6.9.Algeria
9.6.9.1.Market size and forecast, by product type
9.6.9.2.Market size and forecast, by container type
9.6.9.3.Market size and forecast, by formulation
9.6.9.4.Market size and forecast, by application
9.6.9.5.Market size and forecast, by distribution channel
9.6.10.Tunisia
9.6.10.1.Market size and forecast, by product type
9.6.10.2.Market size and forecast, by container type
9.6.10.3.Market size and forecast, by formulation
9.6.10.4.Market size and forecast, by application
9.6.10.5.Market size and forecast, by distribution channel
9.6.11.Libia
9.6.11.1.Market size and forecast, by product type
9.6.11.2.Market size and forecast, by container type
9.6.11.3.Market size and forecast, by formulation
9.6.11.4.Market size and forecast, by application
9.6.11.5.Market size and forecast, by distribution channel
9.6.12.Egypt
9.6.12.1.Market size and forecast, by product type
9.6.12.2.Market size and forecast, by container type
9.6.12.3.Market size and forecast, by formulation
9.6.12.4.Market size and forecast, by application
9.6.12.5.Market size and forecast, by distribution channel
9.6.13.Rest of North Africa
9.6.13.1.Market size and forecast, by product type
9.6.13.2.Market size and forecast, by container type
9.6.13.3.Market size and forecast, by formulation
9.6.13.4.Market size and forecast, by application
9.6.13.5.Market size and forecast, by distribution channel
CHAPTER 10:COMPANY PROFILES
10.1.SANTEN PHARMACEUTICAL
10.1.1.Company overview
10.1.2.Key Executives
10.1.3.Company snapshot
10.1.4.Operating business segments
10.1.5.Product portfolio
10.1.6.Business performance
10.1.7.Key strategic moves and developments
10.2.BAUSCH & LOMB
10.2.1.Company overview
10.2.2.Key Executives
10.2.3.Company snapshot
10.2.4.Operating business segments
10.2.5.Product portfolio
10.2.6.Business performance
10.2.7.Key strategic moves and developments
10.3.ALLERGAN
10.3.1.Company overview
10.3.2.Key Executives
10.3.3.Company snapshot
10.3.4.Operating business segments
10.3.5.Product portfolio
10.3.6.Business performance
10.3.7.Key strategic moves and developments
10.4.ABBOTT LABORATORIES
10.4.1.Company overview
10.4.2.Key Executives
10.4.3.Company snapshot
10.4.4.Operating business segments
10.4.5.Product portfolio
10.4.6.Business performance
10.4.7.Key strategic moves and developments
10.5.JOHNSON & JOHNSON
10.5.1.Company overview
10.5.2.Key Executives
10.5.3.Company snapshot
10.5.4.Operating business segments
10.5.5.Product portfolio
10.5.6.Business performance
10.5.7.Key strategic moves and developments
10.6.LUMECARE
10.6.1.Company overview
10.6.2.Key Executives
10.6.3.Company snapshot
10.6.4.Operating business segments
10.6.5.Product portfolio
10.6.6.Business performance
10.6.7.Key strategic moves and developments
10.7.SIMILASAN CORPORATION
10.7.1.Company overview
10.7.2.Key Executives
10.7.3.Company snapshot
10.7.4.Operating business segments
10.7.5.Product portfolio
10.7.6.Business performance
10.7.7.Key strategic moves and developments
10.8.URSAPHARM
10.8.1.Company overview
10.8.2.Key Executives
10.8.3.Company snapshot
10.8.4.Operating business segments
10.8.5.Product portfolio
10.8.6.Business performance
10.8.7.Key strategic moves and developments
10.9.NOVARTIS AG (ALCON)
10.9.1.Company overview
10.9.2.Key Executives
10.9.3.Company snapshot
10.9.4.Operating business segments
10.9.5.Product portfolio
10.9.6.Business performance
10.9.7.Key strategic moves and developments
10.10.OCUSOFT
10.10.1.Company overview
10.10.2.Key Executives
10.10.3.Company snapshot
10.10.4.Operating business segments
10.10.5.Product portfolio
10.10.6.Business performance
10.10.7.Key strategic moves and developments
TABLE 1.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 2.OTC ARTIFICIAL TEARS MARKET FOR SOLUTION, BY REGION, 2019-2027 ($MILLION)
TABLE 3.OTC ARTIFICIAL TEARS MARKET FOR OINTMENT, BY REGION, 2019-2027 ($MILLION)
TABLE 4.OTC ARTIFICIAL TEARS MARKET FOR EMULSION, BY REGION, 2019-2027 ($MILLION)
TABLE 5.OTC ARTIFICIAL TEARS MARKET FOR GEL, BY REGION, 2019-2027 ($MILLION)
TABLE 6.OTC ARTIFICIAL TEARS MARKET FOR SPRAY SOLUTION, BY REGION, 2019-2027 ($MILLION)
TABLE 7.OTC ARTIFICIAL TEARS MARKET FOR SUSPENSIONS, BY REGION, 2019-2027 ($MILLION)
TABLE 8.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 9.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC SINGLE DOSE CONTAINER, BY REGION, 2019-2027 ($MILLION)
TABLE 10.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC MULTI-DOSE CONTAINER, BY REGION, 2019-2027 ($MILLION)
TABLE 11.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 12.OTC ARTIFICIAL TEARS MARKET FOR PRESERVED SYSTEMS, BY REGION, 2019-2027 ($MILLION)
TABLE 13.OTC ARTIFICIAL TEARS MARKET FOR SPRAY, BY REGION, 2019-2027 ($MILLION)
TABLE 14.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION, 2019-2027 ($MILLION)
TABLE 15.OTC ARTIFICIAL TEARS MARKET FOR PRESERVED SYSTEMS, BY REGION, 2019-2027 ($MILLION)
TABLE 16.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY FORMULATION 2019-2027 ($MILLION)
TABLE 17.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE BASED, BY REGION, 2019-2027 ($MILLION)
TABLE 18.OTC ARTIFICIAL TEARS MARKET FOR NON-PRESERVATIVE BASED, BY REGION, 2019-2027 ($MILLION)
TABLE 19.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY APPLICATION 2019-2027 ($MILLION)
TABLE 20.OTC ARTIFICIAL TEARS MARKET FOR DRY EYE SYNDROME, BY REGION, 2019-2027 ($MILLION)
TABLE 21.OTC ARTIFICIAL TEARS MARKET FOR ALLERGIES, BY REGION, 2019-2027 ($MILLION)
TABLE 22.OTC ARTIFICIAL TEARS MARKET FOR INFECTIONS, BY REGION, 2019-2027 ($MILLION)
TABLE 23.OTC ARTIFICIAL TEARS MARKET FOR UV AND BLUE LIGHT PROTECTION, BY REGION, 2019-2027 ($MILLION)
TABLE 24.OTC ARTIFICIAL TEARS MARKET FOR CONTACT LENS MOISTURE RETENTION, BY REGION, 2019-2027 ($MILLION)
TABLE 25.OTC ARTIFICIAL TEARS MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
TABLE 26.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 27.OTC ARTIFICIAL TEARS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2019-2027 ($MILLION)
TABLE 28.OTC ARTIFICIAL TEARS MARKET FOR DRUG STORE AND RETAIL PHARMACIES, BY REGION, 2019-2027 ($MILLION)
TABLE 29.OTC ARTIFICIAL TEARS MARKET FOR ONLINE PHARMACIES, BY REGION, 2019-2027 ($MILLION)
TABLE 30.OTC ARTIFICIAL TEARS MARKET FOR , BY REGION, , 2019-2027 ($MILLION)
TABLE 31.NORTH AMERICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 32.NORTH AMERICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 33.NORTH AMERICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 34.NORTH AMERICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 35.NORTH AMERICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 36.NORTH AMERICA OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 37.EUROPE OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 38.EUROPE OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 39.EUROPE OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 40.EUROPE OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 41.EUROPE OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 42.EUROPE OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 43.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 44.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 45.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 46.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 47.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 48.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 49.MIDDLE EAST OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 50.MIDDLE EAST OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 51.MIDDLE EAST OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 52.MIDDLE EAST OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 53.MIDDLE EAST OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 54.MIDDLE EAST OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 55.NORTH AFRICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
TABLE 56.NORTH AFRICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
TABLE 57.NORTH AFRICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
TABLE 58.NORTH AFRICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
TABLE 59.NORTH AFRICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
TABLE 60.NORTH AFRICA OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
TABLE 61.SANTEN PHARMACEUTICAL: COMPANY SNAPSHOT
TABLE 62.SANTEN PHARMACEUTICAL: OPERATING SEGMENTS
TABLE 63.BAUSCH & LOMB: COMPANY SNAPSHOT
TABLE 64.BAUSCH & LOMB: OPERATING SEGMENTS
TABLE 65.ALLERGAN: COMPANY SNAPSHOT
TABLE 66.ALLERGAN: OPERATING SEGMENTS
TABLE 67.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 68.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 69.JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 70.JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 71.LUMECARE: COMPANY SNAPSHOT
TABLE 72.LUMECARE: OPERATING SEGMENTS
TABLE 73.SIMILASAN CORPORATION: COMPANY SNAPSHOT
TABLE 74.SIMILASAN CORPORATION: OPERATING SEGMENTS
TABLE 75.URSAPHARM: COMPANY SNAPSHOT
TABLE 76.URSAPHARM: OPERATING SEGMENTS
TABLE 77.NOVARTIS AG (ALCON): COMPANY SNAPSHOT
TABLE 78.NOVARTIS AG (ALCON): OPERATING SEGMENTS
TABLE 79.OCUSOFT: COMPANY SNAPSHOT
TABLE 80.OCUSOFT: OPERATING SEGMENTS
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
